Fineline Cube

Follow:
14409 Articles
China's NHC Announces Initiative to Boost Gerontology Medical Services
DrugMedical Device

China’s NHC Announces Initiative to Boost Gerontology Medical Services

Vantive Secures Collaborations with Kertone and Qiantang Longyue at CIIE for Dialysis Solutions
CompanyDeals

Vantive Secures Collaborations with Kertone and Qiantang Longyue at CIIE for Dialysis Solutions

Amgen’s Tavneos Receives NMPA Approval for ANCA-Associated Vasculitis Treatment in China
CompanyDrug

Amgen’s Tavneos Receives NMPA Approval for ANCA-Associated Vasculitis Treatment in China

Boston Scientific Launches Vercisie Genius DBS System in China for Parkinson's Disease Treatment
CompanyMedical Device

Boston Scientific Launches Vercisie Genius DBS System in China for Parkinson’s Disease Treatment

CARSgen Therapeutics Presents Latest CAR-T Data at ASH Annual Meeting
CompanyDrug

CARSgen Therapeutics Presents Latest CAR-T Data at ASH Annual Meeting

Changchun High & New Technology Industries Receives NMPA Approval for Long-Acting Somatropin
CompanyDrug

Changchun High & New Technology Industries Receives NMPA Approval for Long-Acting Somatropin

Huadong Medicine Co., Ltd Receives NMPA Approval for Stelara Biosimilar SaiLeXin
CompanyDrug

Huadong Medicine Co., Ltd Receives NMPA Approval for Stelara Biosimilar SaiLeXin

Northeast Pharmaceutical to Acquire Majority Stake in Dingcheng Peptide Source for RMB 186.8 Million
CompanyDeals

Northeast Pharmaceutical to Acquire Majority Stake in Dingcheng Peptide Source for RMB 186.8 Million

Ascentage Pharma to Present Olverembatinib and Lisaftoclax Clinical Data at ASH Annual Meeting
CompanyDrug

Ascentage Pharma to Present Olverembatinib and Lisaftoclax Clinical Data at ASH Annual Meeting

CStone Pharmaceuticals Presents CS5001 Clinical Data at the ASH Annual Meeting
CompanyDrug

CStone Pharmaceuticals Presents CS5001 Clinical Data at the ASH Annual Meeting

Roche to Showcase 40+ Abstracts on Blood Disorders at ASH Annual Meeting
CompanyDrug

Roche to Showcase 40+ Abstracts on Blood Disorders at ASH Annual Meeting

China Medical System's Opzelura Approved in Hong Kong for Non-segmental Vitiligo Treatment
CompanyDrug

China Medical System’s Opzelura Approved in Hong Kong for Non-segmental Vitiligo Treatment